Ajay Piramal-owned Piramal Enterprises has received shareholders’ approval to demerge its pharmaceuticals business and simplify the corporate structure.
The company received 99 per cent of the votes at the shareholders meeting held, PEL said in a statement.
The demerger will divide the company into two focused entities —financial services and pharmaceuticals.
Copyright © 2024 M&A Critique!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.We have made a sincere effort to ensure that all photographs used on this website are either freely available in the public domain or used with permission. If you believe your work is being used inappropriately, please let us know and we will address the matter immediately.
[ultimatemember form_id=140]
WhatsApp us